University of Florida — Department of Infectious Diseases and Immunology, College of Veterinary Medicine, and Emerging Pathogens Institute
University of Florida researchers develop tools to interrupt malaria transmission, including the AnAPN1/UF6b transmission-blocking vaccine, the SMAART-1 saliva-based rapid test for detecting low-density malaria infections, and the HC-04.J7 human liver-cell model for studying malaria parasite infection.
What they do
University of Florida researchers develop tools to interrupt malaria transmission, including the AnAPN1/UF6b transmission-blocking vaccine, the SMAART-1 saliva-based rapid test for detecting low-density malaria infections, and the HC-04.J7 human liver-cell model for studying malaria parasite infection.1 Their U.S. R&D is based in Gainesville, Florida.1 Their work is in the development stage, with UF6b having completed first-in-human evaluation in Gabon and the PSSP17-based diagnostic supported by published research and a granted U.S. patent.1
- Gainesville, FL2,1Research and development
In the field and in development
Partnerships in 3 endemic countries
Who they work with in the United States
- In the atlas
- In the atlas
- NIH/NIAID1Bethesda, MD · Funder · funder — West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR) grant
Where this comes from
- 1Confirmed by the organization
- 2ufrfprofessors.research.ufl.edu
- 3epi.ufl.edu
- 4epi.ufl.edu
- 5doaj.org